Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Groopman

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)|March 22, 2019
Environmental health in the biology century: Transitions from population to personalized preventionJohn D Groopman
Molecular Carcinogenesis|March 26, 2011
Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survivalShoba Iyer, John D Groopman
Toxicology and Applied Pharmacology|June 22, 2005
Role of metabolism and viruses in aflatoxin-induced liver cancerJohn D Groopman, Thomas W Kensler
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescencePeter F Scholl, John D Groopman
Cancer Prevention Research (Philadelphia, Pa.)|December 3, 2009
Is it time to advance the chemoprevention of environmental carcinogenesis with microdosing trials?Thomas W Kensler, John D Groopman
IARC Scientific Publications|September 25, 2012
Physical/chemical/immunologic analytical methodsJia-Sheng Wang, John D Groopman
Annals of the New York Academy of Sciences|May 2, 2003
DNA methylation as a cancer-specific biomarker: from molecules to populationsArti Patel, John D Groopman, Asad Umar
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer riskJohn D Groopman, Denise Johnson, Thomas W Kensler
Pathogens (Basel, Switzerland)|October 23, 2021
Environmental Pollutants, Mucosal Barriers, and Pathogen Susceptibility; The Case for Aflatoxin B<sub>1</sub> as a Risk Factor for HIV Transmission and PathogenesisErin P Madeen, Frank Maldarelli, John D Groopman
Annual Review of Food Science and Technology|January 16, 2014
Public health impacts of foodborne mycotoxinsFelicia Wu, John D Groopman, James J Pestka
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Experimental Biology and Medicine (Maywood, N.J.)|March 22, 2019
Environmental health in the biology century: Transitions from population to personalized preventionJohn D Groopman
Molecular Carcinogenesis|March 26, 2011
Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survivalShoba Iyer, John D Groopman
Toxicology and Applied Pharmacology|June 22, 2005
Role of metabolism and viruses in aflatoxin-induced liver cancerJohn D Groopman, Thomas W Kensler
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescencePeter F Scholl, John D Groopman
Cancer Prevention Research (Philadelphia, Pa.)|December 3, 2009
Is it time to advance the chemoprevention of environmental carcinogenesis with microdosing trials?Thomas W Kensler, John D Groopman
IARC Scientific Publications|September 25, 2012
Physical/chemical/immunologic analytical methodsJia-Sheng Wang, John D Groopman
Annals of the New York Academy of Sciences|May 2, 2003
DNA methylation as a cancer-specific biomarker: from molecules to populationsArti Patel, John D Groopman, Asad Umar
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer riskJohn D Groopman, Denise Johnson, Thomas W Kensler
Pathogens (Basel, Switzerland)|October 23, 2021
Environmental Pollutants, Mucosal Barriers, and Pathogen Susceptibility; The Case for Aflatoxin B<sub>1</sub> as a Risk Factor for HIV Transmission and PathogenesisErin P Madeen, Frank Maldarelli, John D Groopman
Annual Review of Food Science and Technology|January 16, 2014
Public health impacts of foodborne mycotoxinsFelicia Wu, John D Groopman, James J Pestka
Pageof 13